Scientists have reported a major breakthrough in our understanding of inflammatory bowel disorder. It could lead to more effective treatments for conditions like Crohn's disease, a new study found.

A lthough some health conditions are spoken about with more nuance and understanding than in the past, inflammatory bowel ...

We’ve historically been obsessed with constipation. It’s shaped how we think about the gut, writes Elsa Richardson.

An anti-TL1A monoclonal antibody called tulisokibart may help people with moderate to severe ulcerative colitis achieve ...

A new study found that the average frequency of your bowel movements could impact your microbiome and risk of chronic disease ...

Advertisement Ulcerative colitis affects over 900,000 Americans and is a form of inflammatory bowel disease (IBD). The exact ...

LGBTQ patients afflicted with inflammatory bowel disease, an autoimmune condition that affects some 2 million to 3 million ...

A three-day National Inflammatory Bowel Disease (IBD) Conference and the second roundtable meeting of the BRICS IBD Consortium, being organised by the Vizag Gut Club Association in collaboration with ...

Hidradenitis suppurativa is a chronic, systemic, and often painful skin condition. Here’s what it’s like living with it.

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

Tulisokibart is a tumor necrosis factor (TNF)-like cytokine 1A (TL1A) monoclonal antibody with a different mechanism of ...

A retrospective study of a mandatory nonmedical switch in Canada found no significant differences in rates of treatment persistence, loss of response, or adverse events in patients with inflammatory ...